Core Viewpoint - As of October 24, 2025, the stock price of Kangtong Medical (301515) closed at 21.92 yuan, reflecting a slight increase of 0.09% with a trading volume of 1.06 million shares and a total transaction value of 23.36 million yuan [1] Financial Performance - Kangtong Medical reported a main revenue of 265 million yuan for the first half of 2025, a year-on-year decline of 39.29% [3] - The net profit attributable to shareholders was -8.4044 million yuan, a year-on-year decrease of 154.53% [3] - The second quarter of 2025 saw a single-quarter main revenue of 241 million yuan, down 33.22% year-on-year, and a net profit of -9.9834 million yuan, a decline of 312.13% [3] - The company’s gross profit margin stood at 22.09%, significantly lower than the industry average of 51.33% [3] Market Position - The total market capitalization of Kangtong Medical is 2.192 billion yuan, which is below the industry average of 11.653 billion yuan, ranking 118 out of 124 in the medical device industry [3] - The company’s price-to-earnings ratio (P/E) is -130.41, compared to the industry average of 95.02, indicating a challenging profitability outlook [3] - The return on equity (ROE) is -0.67%, while the industry average is 2.09%, reflecting underperformance in generating returns for shareholders [3] Capital Flow Analysis - On October 24, 2025, the net inflow of main funds was 1.4429 million yuan, accounting for 6.18% of the total transaction value [2] - Retail investors experienced a net outflow of 1.0009 million yuan, representing 4.28% of the total transaction value [2] - Over the past five days, the stock has seen fluctuating capital flows, with significant net outflows from main and retail investors on several days [2]
股票行情快报：港通医疗（301515）10月24日主力资金净买入144.29万元